Assessment of in vivo versus in vitro biofilm formation of clinical methicillin-resistant Staphylococcus aureus isolates from endotracheal tubes

dc.contributor.author
Fernández Barat, Laia
dc.contributor.author
Ben-Aicha, Soumaya
dc.contributor.author
Motos, Ana
dc.contributor.author
Vila Estapé, Jordi
dc.contributor.author
Marco Reverté, Francesc
dc.contributor.author
Rigol Muxart, Montserrat
dc.contributor.author
Muñoz López, Laura
dc.contributor.author
Bassi, Gianluigi Li
dc.contributor.author
Ferrer Monreal, Miquel
dc.contributor.author
Torres Martí, Antoni
dc.date.issued
2018-11-14T19:34:01Z
dc.date.issued
2018-11-14T19:34:01Z
dc.date.issued
2018-08-09
dc.date.issued
2018-11-14T19:34:01Z
dc.identifier
2045-2322
dc.identifier
https://hdl.handle.net/2445/126116
dc.identifier
681796
dc.identifier
30093624
dc.description.abstract
Our aim was to demonstrate that biofilm formation in a clinical strain of methicillin-resistant Staphylococcus aureus (MRSA) can be enhanced by environment exposure in an endotracheal tube (ETT) and to determine how it is affected by systemic treatment and atmospheric conditions. Second, we aimed to assess biofilm production dynamics after extubation. We prospectively analyzed 70 ETT samples obtained from pigs randomized to be untreated (controls, n = 20), or treated with vancomycin (n = 32) or linezolid (n = 18). A clinical MRSA strain (MRSA-in) was inoculated in pigs to create a pneumonia model, before treating with antibiotics. Tracheally intubated pigs with MRSA severe pneumonia, were mechanically ventilated for 69 ± 16 hours. All MRSA isolates retrieved from ETTs (ETT-MRSA) were tested for their in vitro biofilm production by microtiter plate assay. In vitro biofilm production of MRSA isolates was sequentially studied over the next 8 days post-extubation to assess biofilm capability dynamics over time. All experiments were performed under ambient air (O2) or ambient air supplemented with 5% CO2. We collected 52 ETT-MRSA isolates (placebo N = 19, linezolid N = 11, and vancomycin N = 22) that were clonally identical to the MRSA-in. Among the ETT-MRSA isolates, biofilm production more than doubled after extubation in 40% and 50% under 5% CO2 and O2, respectively. Systemic antibiotic treatment during intubation did not affect this outcome. Under both atmospheric conditions, biofilm production for MRSA-in was at least doubled for 9 ETT-MRSA isolates, and assessment of these showed that biofilm production decreased progressively over a 4-day period after extubation. In conclusion, a weak biofilm producer MRSA strain significantly enhances its biofilm production within an ETT, but it is influenced by the ETT environment rather than by the systemic treatment used during intubation or by the atmospheric conditions used for bacterial growth.
dc.format
9 p.
dc.format
application/pdf
dc.format
application/pdf
dc.language
eng
dc.publisher
Nature Publishing Group
dc.relation
Reproducció del document publicat a: https://doi.org/10.1038/s41598-018-30494-7
dc.relation
Scientific Reports, 2018, vol. 8, num. 11906
dc.relation
https://doi.org/10.1038/s41598-018-30494-7
dc.rights
cc-by (c) Fernández Barat, Laia et al., 2018
dc.rights
http://creativecommons.org/licenses/by/3.0/es
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Fonaments Clínics)
dc.subject
Staphylococcus aureus
dc.subject
Resistència als medicaments
dc.subject
Intubació
dc.subject
Diagnòstic microbiològic
dc.subject
Staphylococcus aureus
dc.subject
Drug resistance
dc.subject
Intubation
dc.subject
Diagnostic microbiology
dc.title
Assessment of in vivo versus in vitro biofilm formation of clinical methicillin-resistant Staphylococcus aureus isolates from endotracheal tubes
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion


Fitxers en aquest element

FitxersGrandàriaFormatVisualització

No hi ha fitxers associats a aquest element.

Aquest element apareix en la col·lecció o col·leccions següent(s)